91 related articles for article (PubMed ID: 22409818)
1. Preface.
Gisselbrecht C
Best Pract Res Clin Haematol; 2012 Mar; 25(1):1-2. PubMed ID: 22409818
[No Abstract] [Full Text] [Related]
2. [Treatment for localized diffuse large B-cell lymphoma].
Kinoshita T
Rinsho Ketsueki; 2010 Oct; 51(10):1395-401. PubMed ID: 20962472
[No Abstract] [Full Text] [Related]
3. [Diffue large B-cell lymphoma in a child treated by rituximab complicated with chemotherapy].
Chang J; Wang LJ; Wang LZ; Zhang YT; Zhong XD
Zhongguo Dang Dai Er Ke Za Zhi; 2012 May; 14(5):387-8. PubMed ID: 22613114
[No Abstract] [Full Text] [Related]
4. Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary.
Ahbeddou N; Fetohi M; Khanoussi BE; Errihani H
Arch Gynecol Obstet; 2011 May; 283(5):1173-4. PubMed ID: 20957380
[No Abstract] [Full Text] [Related]
5. [Treatment strategy for intravascular large B-cell lymphoma].
Shimada K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():704-8. PubMed ID: 23134032
[No Abstract] [Full Text] [Related]
6. A blind skin biopsy diagnosing an intravascular large B-cell lymphoma.
Deschamps L; Signate A; Delaunay C; Morales I; Warter A; Smadja D; Derancourt C
Eur J Dermatol; 2011; 21(1):114-5. PubMed ID: 21233067
[No Abstract] [Full Text] [Related]
7. Stem cell transplantation for diffuse large B-cell lymphoma patients in the rituximab era.
Mounier N; Gisselbrecht C
Curr Opin Oncol; 2011 Mar; 23(2):209-13. PubMed ID: 21169834
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
Maruyama D
Rinsho Ketsueki; 2011 Oct; 52(10):1645-54. PubMed ID: 21971242
[No Abstract] [Full Text] [Related]
9. Front-line management of diffuse large B cell lymphoma.
Cabanillas F
Curr Opin Oncol; 2010 Nov; 22(6):642-5. PubMed ID: 20811278
[TBL] [Abstract][Full Text] [Related]
10. Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?
Cheah CY; Seymour JF
Leuk Lymphoma; 2014 Mar; 55(3):471-3. PubMed ID: 23906017
[No Abstract] [Full Text] [Related]
11. Diffuse large B cell lymphoma: how can we cure more patients in 2012?
Moskowitz C
Best Pract Res Clin Haematol; 2012 Mar; 25(1):41-7. PubMed ID: 22409822
[TBL] [Abstract][Full Text] [Related]
12. Prevention of CNS relapse in diffuse large B-cell lymphoma.
Kridel R; Dietrich PY
Lancet Oncol; 2011 Dec; 12(13):1258-66. PubMed ID: 21933751
[TBL] [Abstract][Full Text] [Related]
13. Relapses, treatments and new drugs.
Mounier N; Gisselbrecht C
Best Pract Res Clin Haematol; 2012 Mar; 25(1):49-60. PubMed ID: 22409823
[TBL] [Abstract][Full Text] [Related]
14. Do hepatitis C Virus genotypes influence liver dysfunction following rituximab-containing regimens in patients with diffuse large B cell lymphoma?
Toshikuni N; Maeda T; Ueda Y
Acta Haematol; 2012; 127(3):178-81. PubMed ID: 22343527
[No Abstract] [Full Text] [Related]
15. Waxing and waning intravascular large cell lymphoma with widespread organ infiltration.
Vos JM; Bordbar A; Vet RJ; Pals ST; Kater AP
Leuk Lymphoma; 2011 Apr; 52(4):705-8. PubMed ID: 21190427
[No Abstract] [Full Text] [Related]
16. Ocular adnexal diffuse large B-cell lymphoma: local disease correlates with better outcomes.
Madge SN; McCormick A; Patel I; Hatef E; Menon V; Prabhakaran VC; Irion L; Bonshek R; Honovar S; Leatherbarrow B; Esmaeli B; Selva D
Eye (Lond); 2010 Jun; 24(6):954-61. PubMed ID: 19942938
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.
Tanaka T; Shimada K; Yamamoto K; Hirooka Y; Niwa Y; Sugiura I; Kitamura K; Kosugi H; Kinoshita T; Goto H; Nakamura S
Ann Hematol; 2012 Mar; 91(3):383-90. PubMed ID: 21822617
[TBL] [Abstract][Full Text] [Related]
18. [Subcutaneous administration of MabThera for therapy of non-Hodgkin lymphomas frees patients and medical personnel].
Pflege Z; 2013 Apr; 66(4):253. PubMed ID: 23634557
[No Abstract] [Full Text] [Related]
19. [Acute lung injury in a patient with concurrent diffuse large B-cell lymphoma and myelodysplastic syndrome].
Tokuyama T; Muta T; Yasunaga M; Nakanishi H; Ueda Y; Fujisaki T
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1733-7. PubMed ID: 21996978
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
Tai WM; Chung J; Tang PL; Koo YX; Hou X; Tay KW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Jul; 90(7):809-18. PubMed ID: 21229246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
